256 related articles for article (PubMed ID: 24070097)
1. NIHR Medicines for Children Research Network: improving children's health through clinical research.
Rose AC; Van't Hoff W; Beresford MW; Tansey SP
Expert Rev Clin Pharmacol; 2013 Sep; 6(5):581-7. PubMed ID: 24070097
[TBL] [Abstract][Full Text] [Related]
2. Excellence in Family Paediatricians: the FIMP-MCRN (Medicines for Children Research Network) becomes a member of ENPR-EMA (European Network of Paediatric Research at the European Medicines Agency).
Napoleone E
Ital J Pediatr; 2011 Jan; 37():7. PubMed ID: 21247483
[TBL] [Abstract][Full Text] [Related]
3. A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA).
Ruperto N; Eichler I; Herold R; Vassal G; Giaquinto C; Hjorth L; Valls-i-Soler A; Peters C; Helms PJ; Saint Raymond A
Arch Dis Child; 2012 Mar; 97(3):185-8. PubMed ID: 22123735
[No Abstract] [Full Text] [Related]
4. The FIMP Medicines for Children Research Network.
Napoleone E; Mele G
Ital J Pediatr; 2010 Jun; 36():46. PubMed ID: 20591168
[TBL] [Abstract][Full Text] [Related]
5. German Paediatric Research Network (PAED-Net).
Seibert-Grafe M; Butzer R; Zepp F
Paediatr Drugs; 2009; 11(1):11-3. PubMed ID: 19127943
[TBL] [Abstract][Full Text] [Related]
6. Drug evaluation in children 10years after the European pediatric regulation current challenges and perspectives.
Élie V; Leroux S; Kaguelidou F; Jacqz-Aigrain E
Therapie; 2018 Apr; 73(2):113-117. PubMed ID: 29580612
[TBL] [Abstract][Full Text] [Related]
7. NIHR Clinical Research Networks: what they do and how they help paediatric research.
Lythgoe H; Price V; Poustie V; Attar S; Hawcutt D; Preston J; Beresford MW
Arch Dis Child; 2017 Aug; 102(8):755-759. PubMed ID: 28096102
[TBL] [Abstract][Full Text] [Related]
8. Framework conditions facilitating paediatric clinical research.
Knellwolf AL; Bauzon S; Alberighi OD; Lutsar I; Bácsy E; Alfarez D; Panei P
Ital J Pediatr; 2011 Feb; 37():12. PubMed ID: 21345195
[TBL] [Abstract][Full Text] [Related]
9. Recommendations by the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA) Working Group on preparedness of clinical trials about paediatric medicines process.
Siapkara A; Fracasso C; Egger GF; Rizzari C; Trasorras CS; Athanasiou D; Turner MA;
Arch Dis Child; 2021 Dec; 106(12):1149-1154. PubMed ID: 33858819
[TBL] [Abstract][Full Text] [Related]
10. Limited impact of EU paediatric regulation on Finnish clinical trials highlights need for Nordic collaboration.
Korppi M; Lepola P; Vettenranta K; Pakkala S; Hoppu K
Acta Paediatr; 2013 Nov; 102(11):1035-40. PubMed ID: 23889459
[TBL] [Abstract][Full Text] [Related]
11. Usage of unpublished paediatric data.
Saint-Raymond A; Pelle B; Zaccaria C; Sennwitz M; Branch S
Arch Dis Child; 2016 Jan; 101(1):81-4. PubMed ID: 26543071
[TBL] [Abstract][Full Text] [Related]
12. Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study.
Hwang TJ; Tomasi PA; Bourgeois FT
PLoS Med; 2018 Mar; 15(3):e1002520. PubMed ID: 29494592
[TBL] [Abstract][Full Text] [Related]
13. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
Rocchi F; Tomasi P
Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
[TBL] [Abstract][Full Text] [Related]
14. European paediatric research and children's therapeutic needs. A trial review.
Pandolfini C; Bonati M
Acta Paediatr; 2008 Sep; 97(9):1232-7. PubMed ID: 18489618
[TBL] [Abstract][Full Text] [Related]
15. The Dutch Medicines for Children Research Network: a new resource for clinical trials.
Weber EH; Timmermans IT; Offringa M
Paediatr Drugs; 2009; 11(3):161-3. PubMed ID: 19445544
[TBL] [Abstract][Full Text] [Related]
16. The National Institute for Health Research Medicines for Children Research Network.
Nunn T
Paediatr Drugs; 2009; 11(1):14-5. PubMed ID: 19127944
[TBL] [Abstract][Full Text] [Related]
17. Juvenile animal studies and pediatric drug development: a European regulatory perspective.
Carleer J; Karres J
Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):254-60. PubMed ID: 21638754
[TBL] [Abstract][Full Text] [Related]
18. A harmonized and efficient clinical research environment would benefit patients and enhance European competitiveness. Commentary.
Amato A; Aringhieri E; Boccia S; Buccella F; Gorini B; Gramaglia D; Masetti R; Rossi P; Pelicci PG
Ann Ist Super Sanita; 2017; 53(2):104-107. PubMed ID: 28617255
[TBL] [Abstract][Full Text] [Related]
19. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
Rose K
Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
[TBL] [Abstract][Full Text] [Related]
20. Respiratory medicines for children: current evidence, unlicensed use and research priorities.
Smyth AR; Barbato A; Beydon N; Bisgaard H; de Boeck K; Brand P; Bush A; Fauroux B; de Jongste J; Korppi M; O'Callaghan C; Pijnenburg M; Ratjen F; Southern K; Spencer D; Thomson A; Vyas H; Warris A; Merkus PJ
Eur Respir J; 2010 Feb; 35(2):247-65. PubMed ID: 19840958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
